Radiotherapie bei limited SCLC

Translated title of the contribution: Radiotherapy for limited SCLC

A. C. Müller*, J. Dunst

*Corresponding author for this work


The standard treatment of small-cell lung cancer consists of four to six cycles of polychemotherapy and usually includes local thoracic radiation (stages I-III); in principle, surgery is also possible (early stage). When complete remission is achieved, prophylactic whole brain irradiation is recommended. Nevertheless, the standard treatment regimen needs improvement as evidenced by recent statistical data (Symposium on the Interdisciplinary Treatment of Lung Cancer, Münster 2001: median survival 12-16 months, local control 40-60%, 2-year survival 40%, and 5-year survival 20%). Aspects of an optimal integration of radio- and chemotherapy like timing, fractionation and efficacy are represented and discussed in this review. From the current point of view, it can be asserted that thoracic radiotherapy and prophylactic whole brain irradiation are essential to ensure a high rate of long-term survival.

Translated title of the contributionRadiotherapy for limited SCLC
Original languageGerman
Issue number4
Pages (from-to)409-417
Number of pages9
Publication statusPublished - 04.2004


Dive into the research topics of 'Radiotherapy for limited SCLC'. Together they form a unique fingerprint.

Cite this